Strattera is a non-stimulant medication for ADHD that works by increasing norepinephrine in your brain. Common side effects of Strattera include dry mouth, nausea, and reduced appetite. Stimulants ...
Nov. 27, 2002 — Once-daily atomoxetine (Strattera) is effective for children and adolescents with attention deficit hyperactivity disorder (ADHD), according to the results of a randomized, ...
Strattera (atomoxetine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Strattera comes as an oral capsule. Strattera is used in adults and certain ...
March 21, 2011 — In the first randomized controlled trial of atomoxetine (Strattera, Lilly) in young children with attention-deficit/hyperactivity disorder (ADHD ...
British regulators have raised safety concerns with Eli Lilly’s ADHD drug Strattera (atomoxetine).As reported in The Tacoma (Washington) News Tribune, the British Medicine and Healthcare Products ...
Reason for posting: As a nonstimulant, atomoxetine is a popular new treatment for attention-deficit hyperactivity disorder (ADHD). However, the US Food and Drug Administration and Health Canada ...
US drugmaker Eli Lilly says it will update the label of its attention-deficit hyperactivity disorder drug, Strattera (atomoxetine), to carry a "black box" warning, the strongest required by US ...
HYDERABAD, India & Princeton, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Eli Lilly could be facing generic competition far sooner than expected for Strattera, after a US court ruled that a key patent on the attention deficit hyperactivity disorder treatment is invalid. Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback